RCKT
Rocket Pharmaceuticals, Inc. Common Stock
stockNASDAQ
rocket pharmaceuticals, ltd is a biotechnology company focused on seeking cures through molecular and gene therapy. we are developing first-in-class treatments for patients with rare and often devastating orphan diseases using a lentiviral-based gene therapy approach. we have developed rewarding partnerships with a number of leading international research institutions as well as with centers of manufacturing and cell processing expertise, while building an internal team to drive the research, development, clinical and regulatory programs. ultimately we aim to launch and globally commercialize innovative gene therapies in disease areas with high unmet need. for more information, please visit www.rocketpharma.com.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 2.61 | 2026-09-28 | -2.11% | -1.800 |
| 1M | 3.86 | 2026-09-04 | -33.81% | 0.183 |
| 3M | 3.99 | 2026-07-06 | -35.97% | 0.869 |
| 6M | 3.46 | 2026-04-06 | -26.16% | 1.248 |
| 1Y | 3.18 | 2025-10-06 | -19.65% | 1.803 |
| 2Y | 16.41 | 2024-10-04 | -84.43% | — |
| 5Y | 29.26 | 2021-10-05 | -91.27% | 1.677 |
Rocket Pharmaceuticals, Inc. Common Stock (NASDAQ:RCKT) stock price today is $2.56, and today's volume is 1,818,401. RCKT is down 1.351% today. The 30 day average volume is 1.77M. RCKT market cap is $280.47M with 109.77M shares outstanding.